Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP807426.RAv-t6DQFz1vG3uwDXkfUYiOpPYn0_b11pCWqyBADLiNc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807426.RAv-t6DQFz1vG3uwDXkfUYiOpPYn0_b11pCWqyBADLiNc130_assertion type Assertion NP807426.RAv-t6DQFz1vG3uwDXkfUYiOpPYn0_b11pCWqyBADLiNc130_head.
- NP807426.RAv-t6DQFz1vG3uwDXkfUYiOpPYn0_b11pCWqyBADLiNc130_assertion description "[MYCN contributes to tumorigenesis, in part, by repressing miR-184, leading to increased levels of AKT2, a direct target of miR-184.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807426.RAv-t6DQFz1vG3uwDXkfUYiOpPYn0_b11pCWqyBADLiNc130_provenance.
- NP807426.RAv-t6DQFz1vG3uwDXkfUYiOpPYn0_b11pCWqyBADLiNc130_assertion evidence source_evidence_literature NP807426.RAv-t6DQFz1vG3uwDXkfUYiOpPYn0_b11pCWqyBADLiNc130_provenance.
- NP807426.RAv-t6DQFz1vG3uwDXkfUYiOpPYn0_b11pCWqyBADLiNc130_assertion SIO_000772 20409325 NP807426.RAv-t6DQFz1vG3uwDXkfUYiOpPYn0_b11pCWqyBADLiNc130_provenance.
- NP807426.RAv-t6DQFz1vG3uwDXkfUYiOpPYn0_b11pCWqyBADLiNc130_assertion wasDerivedFrom befree-2016 NP807426.RAv-t6DQFz1vG3uwDXkfUYiOpPYn0_b11pCWqyBADLiNc130_provenance.
- NP807426.RAv-t6DQFz1vG3uwDXkfUYiOpPYn0_b11pCWqyBADLiNc130_assertion wasGeneratedBy ECO_0000203 NP807426.RAv-t6DQFz1vG3uwDXkfUYiOpPYn0_b11pCWqyBADLiNc130_provenance.